| # | Country | Total Patents | |
|---|---|---|---|
| #1 | China | 2 | |
| #2 | EPO (European Patent Office) | 2 | |
| #3 | WIPO (World Intellectual Property Organization) | 2 | |
| #4 | Australia | 1 | |
| #5 | Brazil | 1 | |
| #6 | Canada | 1 | |
| #7 | Japan | 1 | |
| #8 | United States | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Environmental technology | |
| #4 | Computer technology | |
| #5 | Measurement |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Microorganisms | |
| #3 | Climate change adaptation technologies | |
| #4 | Bioinformatics | |
| #5 | Analysing materials | |
| #6 | Medical preparations |
| # | Name | Total Patents |
|---|---|---|
| #1 | Müller Johannes | 3 |
| #2 | Muller Johannes | 3 |
| #3 | Haberland Annekathrin | 2 |
| #4 | Wenzel Karin | 2 |
| #5 | Mueller Johannes | 1 |
| #6 | Johannes Müller | 1 |
| #7 | Johannes Mueller | 1 |
| Publication | Filing date | Title |
|---|---|---|
| CN109983129A | For inhibiting and/or suppressing the aptamer of TLR9 activation | |
| EP2982756A1 | Aptamers for use against autoantibody-associated diseases |